Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Fresh Tracks Therapeutics...

    NASDAQ: FRTX · Real-Time Price · USD
    0.94
    0.00 (0.00%)
    At close: Feb 28, 2025, 12:19 PM

    Fresh Tracks Therapeutics Statistics

    Share Statistics

    Fresh Tracks Therapeutics has 5.97M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 5.97M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 806

    FTD / Avg. Volume

    n/a
    		 30.23%

    Short Selling Information

    Short Interest

    n/a
    		 n/a

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 n/a

    Valuation Ratios

    The PE ratio is -0.91 and the forward PE ratio is null. Fresh Tracks Therapeutics's PEG ratio is 0.01.

    PE Ratio

    n/a
    		 -0.91

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 0.65

    Forward PS

    n/a
    		 0.3

    PB Ratio

    n/a
    		 0.52

    P/FCF Ratio

    n/a
    		 -1.2

    PEG Ratio

    n/a
    		 0.01
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Fresh Tracks Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 6.98, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 6.98

    Quick Ratio

    n/a
    		 6.98

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 -1272

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $2,001,500

    Profits Per Employee

    n/a
    		 $-1,423,500

    Employee Count

    n/a
    		 4

    Asset Turnover

    n/a
    		 0.69

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by 1.08% in the last 52 weeks. The beta is 1.17, so Fresh Tracks Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.17

    52-Week Price Change

    n/a
    		 1.08%

    50-Day Moving Average

    n/a
    		 0.81

    200-Day Moving Average

    n/a
    		 0.82

    Relative Strength Index (RSI)

    n/a
    		 76.87

    Average Volume (20 Days)

    n/a
    		 2,666

    Income Statement

    In the last 12 months, Fresh Tracks Therapeutics had revenue of 8.01M and earned -5.69M in profits. Earnings per share was -0.96.

    Revenue

    n/a
    		 8.01M

    Gross Profit

    n/a
    		 8.01M

    Operating Income

    n/a
    		 -6.36M

    Net Income

    n/a
    		 -5.69M

    EBITDA

    n/a
    		 -5.65M

    EBIT

    n/a
    		 -5.69M

    Earnings Per Share (EPS)

    n/a
    		 -0.96
    Full Income Statement

    Balance Sheet

    The company has 10.87M in cash and 0 in debt, giving a net cash position of 10.87M.

    Cash & Cash Equivalents

    n/a
    		 10.87M

    Total Debt

    n/a
    		 n/a

    Net Cash

    n/a
    		 n/a

    Retained Earnings

    n/a
    		 -172.16M

    Total Assets

    n/a
    		 11.59M

    Working Capital

    n/a
    		 9.9M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -4.34M and capital expenditures 0, giving a free cash flow of -4.34M.

    Operating Cash Flow

    n/a
    		 -4.34M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -4.34M

    FCF Per Share

    n/a
    		 -0.73
    Full Cash Flow Statement

    Margins

    Gross margin is 100%, with operating and profit margins of -79.44% and -71.12%.

    Gross Margin

    n/a
    		 100%

    Operating Margin

    n/a
    		 -79.44%

    Pretax Margin

    n/a
    		 -71.12%

    Profit Margin

    n/a
    		 -71.12%

    EBITDA Margin

    n/a
    		 -70.55%

    EBIT Margin

    n/a
    		 -79.44%

    FCF Margin

    n/a
    		 -54.25%

    Dividends & Yields

    FRTX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for FRTX.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jul 5, 2022. It was a backward split with a ratio of 1:45.

    Last Split Date

    n/a
    		 Jul 5, 2022

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:45

    Scores

    Altman Z-Score

    n/a
    		 -18.72

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist